OMER

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Omeros Corporation

NASDAQ | OMER

10.26

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 15, 2025)

$285.50M

Market Cap

-

P/E Ratio

-2.31

EPS

$13.60

52 Week High

$2.95

52 Week Low

HEALTHCARE

Sector

OMER Chart

Recent Chart
Price Action

OMER Technicals

Tags:

OMER Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$950K
Total Revenue $0
Cost Of Revenue $950K
Costof Goods And Services Sold $950K
Operating Income -$169M
Selling General And Administrative $50M
Research And Development $120M
Operating Expenses $169M
Investment Income Net -
Net Interest Income -$13M
Interest Income $11M
Interest Expense $25M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $950K
Income Before Tax -$157M
Income Tax Expense $26M
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$158M
Ebitda -$157M
Net Income -$157M

Revenue & Profitability

Earnings Performance

OMER Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $277M
Total Current Assets $134M
Cash And Cash Equivalents At Carrying Value $3.4M
Cash And Short Term Investments $3.4M
Inventory -
Current Net Receivables $37M
Total Non Current Assets $143M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $87M
Other Current Assets $7.2M
Other Non Current Assets -
Total Liabilities $460M
Total Current Liabilities $80M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $27M
Total Non Current Liabilities $380M
Capital Lease Obligations $19M
Long Term Debt $167M
Current Long Term Debt $21M
Long Term Debt Noncurrent -
Short Long Term Debt Total $207M
Other Current Liabilities $47M
Other Non Current Liabilities $196M
Total Shareholder Equity -$183M
Treasury Stock -
Retained Earnings -$910M
Common Stock $580K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$149M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $950K
Capital Expenditures $165K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $82M
Cashflow From Financing $63M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$12M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$157M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$950K
Total Revenue $0
Cost Of Revenue $950K
Costof Goods And Services Sold $950K
Operating Income -$169M
Selling General And Administrative $50M
Research And Development $120M
Operating Expenses $169M
Investment Income Net -
Net Interest Income -$13M
Interest Income $11M
Interest Expense $25M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $950K
Income Before Tax -$157M
Income Tax Expense $26M
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$158M
Ebitda -$157M
Net Income -$157M

OMER News

OMER Profile

Omeros Corporation Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Omeros Corporation is a Seattle-based biopharmaceutical firm that specializes in the discovery, development, and commercialization of novel therapeutics aimed at serious conditions. The company boasts a diverse pipeline featuring both protein and small molecule therapies, targeting critical unmet medical needs in areas such as inflammation, complement-mediated diseases, and central nervous system (CNS) disorders. With a strategic focus on orphan indications, Omeros is well-equipped to drive growth and make significant advancements in patient care, positioning itself as a leader in innovative treatment solutions.

GNPX
+227.64%
$0.82
VHAI
0.00%
$0.00
YYAI
-11.86%
$0.13
VIVK
+73.69%
$0.32
BURU
-19.92%
$0.41
CGBS
-39.47%
$0.03
COOT
+229.53%
$3.18
NVDA
-0.21%
$179.64
TOVX
+55.04%
$0.67
PLUG
-5.64%
$3.82
DFLI
+28.93%
$1.97
BITF
+8.06%
$6.36
CAN
+8.33%
$1.95
RXRX
+12.51%
$6.62
NVTS
+19.66%
$15.04
OMER
+150.24%
$10.26
LAES
+24.79%
$7.65
RGTI
-5.78%
$52.87
RR
+4.34%
$6.73
SSKN
+41.55%
$2.18
TLRY
+5.93%
$1.69
DNN
-1.25%
$3.15
BYND
-12.41%
$0.68
AMD
+9.12%
$238.00
ACHR
-0.17%
$12.99
INTC
+4.05%
$37.07
F
+0.81%
$11.74
YDKG
-86.07%
$0.19
AXDX
-61.36%
$0.03
BBD
+1.42%
$3.19
QS
+7.58%
$18.16
QBTS
+1.64%
$43.77
TSLA
+1.37%
$435.15
IONZ
+11.80%
$2.87
RIG
+5.44%
$3.29
ETHD
+6.14%
$3.76
NEHC
+30.63%
$3.07
FHN
-9.49%
$20.83
SMR
+14.36%
$52.37
SOFI
+0.86%
$28.11
MARA
+4.39%
$23.21
PFAI
+98.42%
$3.79
SOUN
+2.32%
$21.34
UUUU
-8.43%
$24.01
CIFR
+0.86%
$21.07
NOK
+2.74%
$5.62
QSI
+20.74%
$2.59
CRML
-25.52%
$22.32
BAC
+4.51%
$52.34
QUBT
-1.01%
$21.56
HIMS
+18.68%
$64.11
BTG
+5.32%
$5.62
ADAP
+11.62%
$0.17
ONDS
-9.12%
$9.45
IREN
-1.76%
$68.32
BTBT
-1.93%
$4.05
NAK
-5.84%
$2.59
APLD
+8.44%
$38.00
SLNH
+50.53%
$4.20
DVLT
-4.33%
$2.09
VERI
+49.63%
$8.17
TMQ
-21.41%
$8.33
GDXD
-11.92%
$0.66
AAL
+2.25%
$12.46
SEED
+51.91%
$2.18
ATCH
+2.36%
$0.41
JOBY
-2.42%
$17.67
RMBL
+60.50%
$3.21
GPUS
-5.44%
$0.38
ABAT
-23.47%
$8.66
PFE
-0.24%
$24.45
WULF
+2.16%
$15.79
ADD
-25.47%
$0.05
UAMY
-21.43%
$13.72
CLSK
+6.16%
$23.33
RGTZ
+6.70%
$9.39
WWR
-29.45%
$2.45
SRM
+53.27%
$10.30
IONQ
-5.53%
$77.55
NIO
+0.68%
$6.84
KDLY
-7.78%
$0.78
BMNR
+1.48%
$53.70
AMZN
-0.61%
$215.06
NUAI
+15.30%
$3.54
CGC
+6.26%
$1.44
AREC
-27.73%
$4.92
VALE
+1.91%
$11.18
SNAP
-0.27%
$7.89
SANA
+32.22%
$5.88
RIVN
+2.55%
$13.45
ASST
-3.69%
$0.96
HPE
+4.14%
$26.03
PLTR
-0.35%
$179.09
OKLO
-1.67%
$171.21
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NAKA
+0.12%
$0.79
RF
-1.72%
$24.72
CLF
+0.03%
$13.96
USAR
-12.47%
$32.86
GNPX
+227.64%
$0.82
VHAI
0.00%
$0.00
YYAI
-11.86%
$0.13
VIVK
+73.69%
$0.32
BURU
-19.92%
$0.41
CGBS
-39.47%
$0.03
COOT
+229.53%
$3.18
NVDA
-0.21%
$179.64
TOVX
+55.04%
$0.67
PLUG
-5.64%
$3.82
DFLI
+28.93%
$1.97
BITF
+8.06%
$6.36
CAN
+8.33%
$1.95
RXRX
+12.51%
$6.62
NVTS
+19.66%
$15.04
OMER
+150.24%
$10.26
LAES
+24.79%
$7.65
RGTI
-5.78%
$52.87
RR
+4.34%
$6.73
SSKN
+41.55%
$2.18
TLRY
+5.93%
$1.69
DNN
-1.25%
$3.15
BYND
-12.41%
$0.68
AMD
+9.12%
$238.00
ACHR
-0.17%
$12.99
INTC
+4.05%
$37.07
F
+0.81%
$11.74
YDKG
-86.07%
$0.19
AXDX
-61.36%
$0.03
BBD
+1.42%
$3.19
QS
+7.58%
$18.16
QBTS
+1.64%
$43.77
TSLA
+1.37%
$435.15
IONZ
+11.80%
$2.87
RIG
+5.44%
$3.29
ETHD
+6.14%
$3.76
NEHC
+30.63%
$3.07
FHN
-9.49%
$20.83
SMR
+14.36%
$52.37
SOFI
+0.86%
$28.11
MARA
+4.39%
$23.21
PFAI
+98.42%
$3.79
SOUN
+2.32%
$21.34
UUUU
-8.43%
$24.01
CIFR
+0.86%
$21.07
NOK
+2.74%
$5.62
QSI
+20.74%
$2.59
CRML
-25.52%
$22.32
BAC
+4.51%
$52.34
QUBT
-1.01%
$21.56
HIMS
+18.68%
$64.11
BTG
+5.32%
$5.62
ADAP
+11.62%
$0.17
ONDS
-9.12%
$9.45
IREN
-1.76%
$68.32
BTBT
-1.93%
$4.05
NAK
-5.84%
$2.59
APLD
+8.44%
$38.00
SLNH
+50.53%
$4.20
DVLT
-4.33%
$2.09
VERI
+49.63%
$8.17
TMQ
-21.41%
$8.33
GDXD
-11.92%
$0.66
AAL
+2.25%
$12.46
SEED
+51.91%
$2.18
ATCH
+2.36%
$0.41
JOBY
-2.42%
$17.67
RMBL
+60.50%
$3.21
GPUS
-5.44%
$0.38
ABAT
-23.47%
$8.66
PFE
-0.24%
$24.45
WULF
+2.16%
$15.79
ADD
-25.47%
$0.05
UAMY
-21.43%
$13.72
CLSK
+6.16%
$23.33
RGTZ
+6.70%
$9.39
WWR
-29.45%
$2.45
SRM
+53.27%
$10.30
IONQ
-5.53%
$77.55
NIO
+0.68%
$6.84
KDLY
-7.78%
$0.78
BMNR
+1.48%
$53.70
AMZN
-0.61%
$215.06
NUAI
+15.30%
$3.54
CGC
+6.26%
$1.44
AREC
-27.73%
$4.92
VALE
+1.91%
$11.18
SNAP
-0.27%
$7.89
SANA
+32.22%
$5.88
RIVN
+2.55%
$13.45
ASST
-3.69%
$0.96
HPE
+4.14%
$26.03
PLTR
-0.35%
$179.09
OKLO
-1.67%
$171.21
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NAKA
+0.12%
$0.79
RF
-1.72%
$24.72
CLF
+0.03%
$13.96
USAR
-12.47%
$32.86
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.